{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "TWD", "exchange": "TWO", "shortName": "ONENESS BIOTECH CO LTD", "longName": "Oneness Biotech Co., Ltd.", "messageBoardId": "finmb_60410244", "market": "tw_market", "marketState": "POSTPOST", "earningsTimestamp": 1683802740, "earningsTimestampStart": 1691578740, "earningsTimestampEnd": 1692014400, "trailingAnnualDividendRate": 0.1, "trailingPE": 260.0, "trailingAnnualDividendYield": 0.00044642857, "epsTrailingTwelveMonths": 0.85, "sharesOutstanding": 390108000, "bookValue": 37.471, "fiftyDayAverage": 258.73, "fiftyDayAverageChange": -37.73001, "fiftyDayAverageChangePercent": -0.14582774, "twoHundredDayAverage": 247.57, "tradeable": false, "cryptoTradeable": false, "exchangeTimezoneName": "Asia/Taipei", "exchangeTimezoneShortName": "CST", "gmtOffSetMilliseconds": 28800000, "esgPopulated": false, "regularMarketChangePercent": -1.3392857, "regularMarketPrice": 221.0, "regularMarketChange": -3.0, "regularMarketTime": 1684128603, "regularMarketDayHigh": 225.5, "regularMarketDayRange": "217.5 - 225.5", "regularMarketDayLow": 217.5, "regularMarketVolume": 5223690, "regularMarketPreviousClose": 224.0, "bid": 221.0, "ask": 221.5, "bidSize": 0, "askSize": 0, "fullExchangeName": "Taipei Exchange", "financialCurrency": "TWD", "regularMarketOpen": 223.5, "averageDailyVolume3Month": 5289357, "averageDailyVolume10Day": 3859400, "fiftyTwoWeekLowChange": 65.5, "fiftyTwoWeekLowChangePercent": 0.42122185, "fiftyTwoWeekRange": "155.5 - 309.5", "fiftyTwoWeekHighChange": -88.5, "fiftyTwoWeekHighChangePercent": -0.28594506, "fiftyTwoWeekLow": 155.5, "fiftyTwoWeekHigh": 309.5, "twoHundredDayAverageChange": -26.570007, "twoHundredDayAverageChangePercent": -0.10732321, "marketCap": 91217305600, "priceToBook": 5.8978944, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "firstTradeDateMilliseconds": 1316739600000, "priceHint": 2, "symbol": "4743.TWO"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "No.236, Xinyi Road", "address2": "11th Floor Sec. 4 Da\u2019an district", "city": "Taipei", "zip": "106", "country": "Taiwan", "phone": "886 2 2703 1098", "fax": "886 2 2703 1200", "website": "https://www.onenessbio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Oneness Biotech Co., Ltd. engages in the research, development, and sale of new drugs, pharmaceutical, and health products in Taiwan. It operates through New Drug Research and Development, and Agricultural Products Cultivation segments. The company develops ON101, which is in Phase III clinical trials for treating chronic diabetic foot ulcers; and OB318, an anti-cancer drug that is in Phase I clinical trials. It is also developing FB704A that has completed Phase I clinical trial for the treatment of rheumatoid arthritis; FB825, which is in Phase IIa clinical trial for treating atopic dermatitis, allergic diseases, and asthma; and FB918, an antibody targeting the interleukin 33 that is in pre-clinical stage for the treatment of asthma. In addition, the company engages in the management of agriculture cultivation and trading business; and sale of agricultural products. Oneness Biotech Co., Ltd. was incorporated in 2008 and is headquartered in Taipei, Taiwan.", "companyOfficers": [{"maxAge": 1, "name": "Ms. Chih-Hui  Cheng", "title": "GM & Supervisor of Corp. Governance", "fiscalYear": 2021, "totalPay": {"raw": 2769000, "fmt": "2.77M", "longFmt": "2,769,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Shyi-Gen  Chen M.D., M.P.H.", "title": "VP & Head of Medical Affairs", "fiscalYear": 2021, "totalPay": {"raw": 12281000, "fmt": "12.28M", "longFmt": "12,281,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Nien-Yi  Chen", "title": "Deputy Gen. Mang. of Antibody New Drug Division;", "fiscalYear": 2021, "totalPay": {"raw": 6030000, "fmt": "6.03M", "longFmt": "6,030,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Wen-Tzu  Hsiao", "title": "Acting Spokesperson & Sr. Mang. of Fin. Department", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jui-Ching  Chen Ph.D.", "title": "Director of New Drug Devel. Department", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Kung-Ming  Lu", "title": "Director of Operation Center", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Tzu-Chun  Yang", "title": "Associate Gen. Mang. of Information Technology Department", "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}